Although EIF3H expression was not correlated with gender, age, tumor size or number or serum albumin, bilirubin, HBe or HBs antigen, ALT or AFT, the presence of encapsulation, metastasis, or macro-vascular invasion, or Edmondson grade and BCLC stage, high EIF3H expression was more frequently observed in HCC patients with microvascular invasion (p =0.001; Table 1) and advanced tumor-node-metastasis T stage (p =0.009; Table 1). The gene discussed is GPT; the disease is hepatocellular carcinoma.